From: Performance of cytokine models in predicting SLE activity
Parameter | Active SLE (n = 51) | Inactive SLE (n = 73) | p value |
---|---|---|---|
Age, year (mean ± SD) | 35.79 ± 14.31 | 41.01 ± 12.71 | 1.000 |
Gender, male, n (%) | 2 (3.92) | 4 (5.48) | 1.000 |
Female, n (%) | 49 (96.08) | 69 (94.52) | Â |
BMI, kg/m2, (#) | 21.25 (14.67–30.85) | 23.06 (15.89–46.70) | 1.000 |
Age onset, year (mean ± SD) | 29.55 ± 14.25 | 31.74 ± 12.50 | 1.000 |
Disease duration, month, (#) | 63.63 (0–383.40) | 102.90 (4.40–482.10) | 1.000 |
Duration of last active, month, (#) *** | 2.50 (0–13.00) | 8.20 (0.90–165.10) | < 0.001 |
Hypertension, n (%) | 6 (11.76) | 9 (12.33) | 1.000 |
Diabetes mellitus, n (%) | 4 (7.84) | 5 (6.85) | 1.000 |
Clinical SLEDAI score, (#) *** | 8 (1–36) | 0 | < 0.001 |
ESR, mm/h (#) | 33 (5–120) | 22 (5–98) | 0.519 |
 ESR < 20 mm/h, n (%) | 15 (29.4) | 34 (46.6) | 1.000 |
 ESR > 20 mm/h, n (%) | 36 (70.6) | 39 (53.4) | 1.000 |
WBC, cells/mm3 (#) | 6220 (2700-17,290) | 5500 (3060-13,940) | 1.000 |
Hemoglobin, g/dl (#) * | 12.00 (6.70–14.00) | 12.00 (9.30–15.60) | 0.034 |
Platelet, ×103 cells/mm3 (#) | 271 (57–458) | 262 (127–445) | 1.000 |
Serum creatinine, mg/dl (#) | 0.80 (0.40–1.89) | 0.70 (0.50–1.28) | 1.000 |
UPCR, (#) | 1.71 (0.12–33.33) | 0.12 (0.03–0.40) | 0.534 |
 UPCR < 0.5, n (%) *** | 22 (43.1) | 73 (100) | < 0.001 |
 UPCR > 0.5, n (%) *** | 29 (56.9) | 0 (0) | < 0.001 |
 UPCR > 1.0, n (%) *** | 20 (39.2) | 0 (0) | < 0.001 |